153 related articles for article (PubMed ID: 28544137)
1. Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34.
Robke L; Laraia L; Carnero Corrales MA; Konstantinidis G; Muroi M; Richters A; Winzker M; Engbring T; Tomassi S; Watanabe N; Osada H; Rauh D; Waldmann H; Wu YW; Engel J
Angew Chem Int Ed Engl; 2017 Jul; 56(28):8153-8157. PubMed ID: 28544137
[TBL] [Abstract][Full Text] [Related]
2. Development of in vitro PIK3C3/VPS34 complex protein assay for autophagy-specific inhibitor screening.
Kim TM; Baek JH; Kim JH; Oh MS; Kim J
Anal Biochem; 2015 Jul; 480():21-7. PubMed ID: 25862085
[TBL] [Abstract][Full Text] [Related]
3. Beclin 1-ATG14L Protein-Protein Interaction Inhibitor Selectively Inhibits Autophagy through Disruption of VPS34 Complex I.
Pavlinov I; Salkovski M; Aldrich LN
J Am Chem Soc; 2020 May; 142(18):8174-8182. PubMed ID: 32320221
[TBL] [Abstract][Full Text] [Related]
4. Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib.
Dyczynski M; Yu Y; Otrocka M; Parpal S; Braga T; Henley AB; Zazzi H; Lerner M; Wennerberg K; Viklund J; Martinsson J; Grandér D; De Milito A; Pokrovskaja Tamm K
Cancer Lett; 2018 Oct; 435():32-43. PubMed ID: 30055290
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Autophagy Specific Lipid Kinase VPS34 for Cancer Treatment: An Integrative Repurposing Strategy.
Murali P; Verma K; Rungrotmongkol T; Thangavelu P; Karuppasamy R
Protein J; 2021 Feb; 40(1):41-53. PubMed ID: 33400087
[TBL] [Abstract][Full Text] [Related]
6. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
7. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.
Ronan B; Flamand O; Vescovi L; Dureuil C; Durand L; Fassy F; Bachelot MF; Lamberton A; Mathieu M; Bertrand T; Marquette JP; El-Ahmad Y; Filoche-Romme B; Schio L; Garcia-Echeverria C; Goulaouic H; Pasquier B
Nat Chem Biol; 2014 Dec; 10(12):1013-9. PubMed ID: 25326666
[TBL] [Abstract][Full Text] [Related]
8. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
9. The identification and characterisation of autophagy inhibitors from the published kinase inhibitor sets.
Zachari M; Rainard JM; Pandarakalam GC; Robinson L; Gillespie J; Rajamanickam M; Hamon V; Morrison A; Ganley IG; McElroy SP
Biochem J; 2020 Feb; 477(4):801-814. PubMed ID: 32011652
[TBL] [Abstract][Full Text] [Related]
10. Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.
Yuen CK; Wong WM; Mak LF; Wang X; Chu H; Yuen KY; Kok KH
J Med Virol; 2021 Apr; 93(4):2076-2083. PubMed ID: 33026649
[TBL] [Abstract][Full Text] [Related]
11. Selective autophagy inhibition through disruption of the PIK3C3-containing complex I.
Pavlinov I; Salkovski M; Aldrich LN
Autophagy; 2020 Aug; 16(8):1547-1549. PubMed ID: 32619130
[TBL] [Abstract][Full Text] [Related]
12. Ehrlichia secretes Etf-1 to induce autophagy and capture nutrients for its growth through RAB5 and class III phosphatidylinositol 3-kinase.
Lin M; Liu H; Xiong Q; Niu H; Cheng Z; Yamamoto A; Rikihisa Y
Autophagy; 2016 Nov; 12(11):2145-2166. PubMed ID: 27541856
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping Reveals Targets of a Pseudo-Natural-Product Autophagy Inhibitor.
Foley DJ; Zinken S; Corkery D; Laraia L; Pahl A; Wu YW; Waldmann H
Angew Chem Int Ed Engl; 2020 Jul; 59(30):12470-12476. PubMed ID: 32108411
[TBL] [Abstract][Full Text] [Related]
14. SAR405, a PIK3C3/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells.
Pasquier B
Autophagy; 2015 Apr; 11(4):725-6. PubMed ID: 25905679
[TBL] [Abstract][Full Text] [Related]
15. Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors.
Huang SC; Adhikari S; Brownell JE; Calderwood EF; Chouitar J; D'Amore NR; England DB; Foley K; Harrison SJ; LeRoy PJ; Lok D; Lublinsky A; Ma LT; Menon S; Yang Y; Zhang J; Gould AE
Bioorg Med Chem; 2020 Oct; 28(19):115681. PubMed ID: 32912429
[TBL] [Abstract][Full Text] [Related]
16. Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors.
Pasquier B; El-Ahmad Y; Filoche-Rommé B; Dureuil C; Fassy F; Abecassis PY; Mathieu M; Bertrand T; Benard T; Barrière C; El Batti S; Letallec JP; Sonnefraud V; Brollo M; Delbarre L; Loyau V; Pilorge F; Bertin L; Richepin P; Arigon J; Labrosse JR; Clément J; Durand F; Combet R; Perraut P; Leroy V; Gay F; Lefrançois D; Bretin F; Marquette JP; Michot N; Caron A; Castell C; Schio L; McCort G; Goulaouic H; Garcia-Echeverria C; Ronan B
J Med Chem; 2015 Jan; 58(1):376-400. PubMed ID: 25402320
[TBL] [Abstract][Full Text] [Related]
17. Ironing out VPS34 inhibition.
Marsh T; Debnath J
Nat Cell Biol; 2015 Jan; 17(1):1-3. PubMed ID: 25679028
[TBL] [Abstract][Full Text] [Related]
18. Novel and conventional inhibitors of canonical autophagy differently affect LC3-associated phagocytosis.
Stempels FC; Janssens MH; Ter Beest M; Mesman RJ; Revelo NH; Ioannidis M; van den Bogaart G
FEBS Lett; 2022 Feb; 596(4):491-509. PubMed ID: 35007347
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Characterization of VPS34 Lipid Kinase Inhibition by Small Molecules.
Fassy F; Dureuil C; Lamberton A; Mathieu M; Michot N; Ronan B; Pasquier B
Methods Enzymol; 2017; 587():447-464. PubMed ID: 28253972
[TBL] [Abstract][Full Text] [Related]
20. 2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.
Ledeboer MW; Pierce AC; Duffy JP; Gao H; Messersmith D; Salituro FG; Nanthakumar S; Come J; Zuccola HJ; Swenson L; Shlyakter D; Mahajan S; Hoock T; Fan B; Tsai WJ; Kolaczkowski E; Carrier S; Hogan JK; Zessis R; Pazhanisamy S; Bennani YL
Bioorg Med Chem Lett; 2009 Dec; 19(23):6529-33. PubMed ID: 19857967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
